Polaryx Therapeutics, Inc.

US$1.80As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:PLYXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (96.56%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$89.72M
ROIC (46.02%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.98
10.06%
(46.99%)
Hold 1|12|6|3|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.03
0.03
0.03
24.62%
20.37%
15.59%
13.61%
Revenue$M
9.039
8.780
8.561
8.960
10.11%
2.02%
(1.53%)
(0.42%)
Peers (US$89.72M)
Cap (US$)
PE
90.26M
—
90.19M
—
Capital
TTM
5Y
10Y
Leveragex
0.237
—
—
EBIT/Intx
0.445
0.099
0.105
Own earn%
352.45
67.83
72.48
Sh yield%
45.59
19.03
19.46
Owners
Insiders/Inst%
6.53
81.74
Short interest%
0.92
SBC / revenue%
2.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
13–19
$1 testx
−0.1
Incr. ROIC%
11